MaxCyte MXCT Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MaxCyte's change in deferred revenue?
- MaxCyte (MXCT) reported change in deferred revenue of -$327K in Q1 2026.
- How has MaxCyte's change in deferred revenue changed year-over-year?
- MaxCyte's change in deferred revenue increased by 75.3% year-over-year, from -$1.33M to -$327K.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.